Bioleaders Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 26,122.84 million compared to KRW 24,730.31 million a year ago. Net loss was KRW 838.1 million compared to KRW 2,976.11 million a year ago.

Basic loss per share from continuing operations was KRW 29 compared to KRW 105 a year ago. Diluted loss per share from continuing operations was KRW 57. Basic loss per share was KRW 29 compared to KRW 105 a year ago.

Diluted loss per share was KRW 57.